Is there a suitable way to purchase genuine temsitumumab?

By blocking the binding of CTLA-4 to CD80/CD86 ligands, temsitumumab inhibits the inhibitory effect of tumor cells on T cells, enhances the activity of T cells, and promotes the immune system to clear tumor cells. Its genuine purchase channels and correct usage are crucial to the therapeutic effect. Currently, patients can obtain genuine drugs through hospitals, regular pharmacies and professional medical service institutions in listed countries.

Is there a suitable way to purchase genuine temsitumumab?

To obtain genuine temsitumumab , you need to choose formal channels to ensure drug quality and therapeutic effect. There are currently three main reliable ways to buy.

Hospital purchase in listed countries

In countries where marketing has been approved, large general hospitals and oncology hospitals are usually equipped with this drug. Patients need to provide a valid prescription, which will be dispensed directly by the hospital pharmacy. In this way, they can obtain professional medical guidance.

Purchase from pharmacies in listed countries

Franchised pharmacies in some countries are authorized to sell special drugs. Selecting a qualified regular pharmacy and checking the drug batch number and expiration date can ensure you get genuine drugs.

Medical service agency assistance

Professional cross-border medical service agencies can assist patients in contacting regular overseas medical institutions. These institutions are familiar with the international drug procurement process and can provide one-stop services from consultation to distribution.

When choosing purchasing channels, you should focus on examining the institutional qualifications and drug sources, and avoid purchasing through informal channels to prevent counterfeit and shoddy products.

Usage and dosage of temsitumumab

Strictly following the standard medication regimen is crucial to ensure the therapeutic effect. temsitumumab needs to be used in combination with durvalumab. The specific regimen is as follows.

Initial combination therapy phase

Patients weighing 30 kg and above will be treated with temsilimumab 1300 mg on day 1 of cycle 1, followed by imrvalumab 1500 mg. This stage requires the supervision of professional medical staff.

Maintenance treatment phase

After combined treatment, use durvalumab 1500 mg alone every 4 weeks. The treatment cycle needs to be continued until disease progression or intolerable toxicity occurs.

Medication Precautions

Before each dose, the patient’s status needs to be assessed, and blood routine and liver function should be monitored. The infusion process needs to be closely observed, and any abnormal reactions should be dealt with immediately.

Standardized medication can maximize the efficacy of the drug. Patients should strictly follow the doctor's instructions and are not allowed to adjust the dosage on their own.

Daily care for lung cancer patients

Scientific and reasonable daily care plays an important role in improving patients' quality of life and cooperating with drug treatment.

Respiratory tract management

Keep the indoor air fresh and the humidity appropriate. Learn effective coughing methods and practice deep breathing regularly. If you have difficulty breathing, seek medical advice promptly.

Nutritional support

Choose high-protein, high-calorie, easy-to-digest foods. Eat small, frequent meals and ensure adequate fluid intake. Loss of appetite may occur during treatment, and special attention needs to be paid to nutritional status.

Activities and rest

Carry out moderate activities according to physical condition, such as walking and simple housework. Get enough sleep and avoid overexertion. Pay attention to safety during activities and prevent falls.

Good daily care can improve the patient's physical condition and create favorable conditions for drug treatment. Family members should learn relevant nursing knowledge.